Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy-Reference-Cited by-同舟云学术

Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy

Published:2017-10-17 Issue:12 Volume:14 Page:1119-1130
ISSN:1478-9450
Container-title:Expert Review of Proteomics
language:en
Short-container-title:Expert Review of Proteomics

Author:

Silva Lakmali Munasinghage¹,Clements Judith Ann²

Affiliation:

1. Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA

2. School of Biomedical Sciences, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Translational Research Institute, Woolloongabba, Australia

Funder

Australia-India Strategic Research Fund

Cancer Council Queensland

the Wesley Medical Research Foundation

The National Health and Medical Research Council (NHMRC) of Australia

Publisher

Informa UK Limited

Subject

Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14789450.2017.1389637

Reference113 articles.

1. The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions

2. The emerging roles of human tissue kallikreins in cancer

3. Tissue-specific Expression Patterns and Fine Mapping of the Human Kallikrein (KLK) Locus on Proximal 19q13.4

4. Identification and Characterization of KLK14, a Novel Kallikrein Serine Protease Gene Located on Human Chromosome 19q13.4 and Expressed in Prostate and Skeletal Muscle

5. Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein Locus

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer;British Journal of Cancer;2018-10